Investigational antiamyloid monoclonal antibodies may offer a novel pathway to disease reversal.
|Articles|April 23, 2018
- April 2018 Respiratory Health
- Volume 84
- Issue 4
Can You Read These Rxs? (April 2018)
Can you figure out what these prescriptions say?
Advertisement
SEE THE ANSWER ON PAGE 2.
ANSWER
R x 1 : Luvox 50 mg, #30, one tablet once a day; Buspar 10 mg, #60, one tablet twice a day; Klonopin 0.5 mg, #12, one tablet daily.
SEE THE NEXT PRESCRIPTION ON PAGE 3.
R x 2 : Bactrim DS, #14, one tablet by mouth twice a day.
Articles in this issue
over 8 years ago
Smoking Cessation: Where to Begin?over 8 years ago
Case Studies (April 2018)over 8 years ago
COPD: Causes, Stages, and Treatmentsover 8 years ago
Pet Peeves (April 2018)over 8 years ago
Generic Product News (April 2018)over 8 years ago
Rx Product News (April 2018)over 8 years ago
Pertussis: A Preventable Paroxysmal Coughover 8 years ago
OTC Product News (April 2018)over 8 years ago
Calming Acute Coughs With Nonprescription ProductsAdvertisement
Related to this article
Increasingly, pharmacists are leading the obesity management team.
A panel of cardiology pharmacists discussed the diagnostic red flags, evolving treatment landscape, and expanding pharmacist role central to identifying and managing ATTR-CM.
Weight-based norepinephrine dosing did not improve time to goal MAP, and median dose was similar compared with non–weight-based dosing in patients with septic shock.
The panelists emphasized that selecting a therapy is only one step toward improving outcomes for patients with heart failure.
Pharmacists can educate patients about staying up to date on immunizations and discuss fall prevention strategies.
Pharmacists describe their experiences using DEA certificates for controlled substance prescribing in different practice settings, as well as barriers and opportunities for future expansion.
Professional membership and experienced mentor leadership offer new pharmacy technicians a dual advantage, serving as a comprehensive training accelerator.
Advertisement
Advertisement
Trending on Pharmacy Times
1
New Data Reshapes Nonstatin Lipid Therapy Choices
2
Eight Names, One Drug: Why Adalimumab Biosimilars Are Creating Real Confusion at the Counter
3
Etentamig Reduces Risk of Progression or Death by 60% in Relapsed/Refractory Multiple Myeloma
4
From Evidence to Execution: Pharmacists Navigate MRA Selection and Access in HFpEF and HFmrEF
5